paxilline has been researched along with Nephrotic Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chesor, M; Lait, PJ; Lee, RWJ; May, CJ; Saleem, MA; Schewitz-Bowers, LP; Welsh, GI | 1 |
Koukouritaki, SB; Lianos, EA; Tamizuddin, A | 1 |
2 other study(ies) available for paxilline and Nephrotic Syndrome
Article | Year |
---|---|
Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation.
Topics: Cell Movement; Cells, Cultured; Healthy Volunteers; Humans; Interleukin-17; Nephrotic Syndrome; p38 Mitogen-Activated Protein Kinases; Paxillin; Podocytes; Protease Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Th17 Cells | 2019 |
Enhanced expression of the cytoskeletal-associated protein, paxillin, in experimental nephrotic syndrome.
Topics: Animals; Anti-Bacterial Agents; Blotting, Western; Cell Adhesion Molecules; Cells, Cultured; Cytoskeletal Proteins; Disease Models, Animal; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Follow-Up Studies; Nephrotic Syndrome; Paxillin; Phosphoproteins; Protein-Tyrosine Kinases; Puromycin; Rats; Rats, Sprague-Dawley; Receptor, Insulin; rho GTP-Binding Proteins | 1998 |